Sign In

Rob Johnson

Co-Founder & Head, Business Development and Licensing at Affinia Therapeutics

Rob Johnson is an accomplished entrepreneur known for co-founding Affinia Therapeutics, a reputable AAV gene therapy company in Boston, in 2019.

Before his venture with Affinia, he established Alacrita, a prominent pharma and biotech consulting firm, and oversaw the opening of its Boston office in 2012. Johnson successfully managed numerous consulting projects focusing on therapeutic strategy, business development, and valuation.

In addition to his work with Alacrita, he founded Foothold America to assist foreign companies in entering the US market seamlessly.

Prior to his entrepreneurial endeavors, Rob Johnson served as the Head of Business Development at Onyvax Ltd, a company specializing in developing allogeneic whole cell cancer vaccines for prostate cancer.

His educational background includes studies in Corporate Finance and Finance at the London Business School, a Bachelor of Science in Biology from Nottingham University Business School, and education at Oundle School.

Rob Johnson
Add to my network

Location

London, England, United Kingdom